AHA Video: Cohen reviews quality-of-life data of PARTNER, touches upon costs

TriMed Staff | | Cardiovascular Business | Interventional Cardiology
Click to play
AHA Video: David J. Cohen, MD
St. Luke's MidAmerica Heart Institute
Kansas City, Mo.
CHICAGO—David J. Cohen, MD, director of cardiovascular research at St. Luke's MidAmerica Heart Institute in Kansas City, Mo., discusses the positive quality-of-life data for patients with aortic stenosis who are not suitable candidates for surgery, based on a substudy of the PARTNER trial.

Cohen also speaks to how the transcatheter aortic valve implantation technique will translate into real-life clinical practice, outside of the rigorous patient selection process of the PARTNER trial. He hypothesizes how cost-effective the technique could be, if approved in the U.S., based on the European data and the new cost-effective PARTNER substudy that he and his colleagues are undertaking.

TriMed Staff

Related Content

Surgery outperforms PCI in NSTEMI patients with multivessel CAD
Boston Scientific enters IVL arms race with acquisition worth up to $664M
FDA sees value in no-implant heart failure device
Radial secondary access during TAVR limits complications
Medtronic’s Harmony TPVR system gains CE mark approval
History made: Young child treated with new heart device for very first time

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.